Navigation Links
Positive Clinical Data for TASQ - Active Biotech's Novel Treatment,of Prostate Cancer

e cancer is the most common form of cancer among men. The incidence is strongly age-related and is unusual before age 50. In 2006, 2.2 million new cases were estimated to have been diagnosed in the US alone.

Lund, March 9, 2007

Active Biotech AB (publ) Sven Andréasson President and CEO

For further information, please contact: Sven Andréasson, President and CEO, tel. +46 46 19 20 49 Tomas Leanderson, Chief Scientific Officer, tel +46 46 19 20 95 Cecilia Hofvander, Manager Corporate Communication, tel. +46 46 19 11 22

Active Biotech AB is a biotechnology company focusing on research and development of pharmaceuticals. Active Biotech has a strong R&D portfolio with pipeline products focused on autoimmune/inflammatory diseases and cancer. Most advanced projects are laquinimod, an orally administered small molecule with unique immunomodulatory properties for the treatment of multiple sclerosis, as well as ANYARA for use in cancer targeted therapy, the primary indication being renal cancer. Further key projects in clinical development comprise the three orally administered compounds TASQ for prostate cancer 57-57 for SLE and RhuDex® for RA. In addition, the preclinical development of the I-3D project is being conducted in cooperation with Chelsea Therapeutics.

Active Biotech AB (org.nr 556223-9227) P.O. Box 724, SE-220 07 Lund, Sweden Tel +46 46-19 20 00 Fax +46 46-19 20 50


'"/>




Page: 1 2

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
(Date:7/29/2014)... ROCKVILLE, Md. , July 29, 2014  Synthetic ... anti-infective biologic and drug candidates targeting specific pathogens that ... view of the unusual market activity in the Company,s ... Company in accordance with its usual practice. The Company ... unusual market activity. About Synthetic Biologics, Inc. ...
(Date:7/29/2014)... -- New high priced hepatitis C drugs will increase ... $2.9 to $5.8 billion next year, according to a ... by the Pharmaceutical Care Management Association (PCMA). Milliman projects ... much as 8.6 percent in 2015 as a result ... The study finds that the majority of ...
(Date:7/29/2014)... ALBANY, New York , July 29, 2014 /PRNewswire/ ... published by Transparency Market Research "Surgical Navigation Systems Market ... Systems) - Global Industry Analysis, Size, Share, Growth, Trends ... systems market was valued at USD 218.5 million in ... of 4.5% from 2014 to 2020, to reach an ...
Breaking Medicine Technology:Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity 2New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 2Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 3Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 4
(Date:7/29/2014)... (PRWEB) July 29, 2014 Outsourced ... of tripling in the number of hospitals contracting ... 1, 2015 deadline, according to the recently published ... physician leaders, found in the reports “Top Ranked ... hospitals now outsource Clinical documentation audit, review and ...
(Date:7/29/2014)... million this year to support innovative research on ... that affect more than 233,000 Canadians. , ... across Canada. This diverse research will explore genetic ... understanding (and potential treatment) of symptoms and consider ... life. , Crohn,s and Colitis Canada funds ...
(Date:7/29/2014)... 29, 2014 CHI-California Healthcare Institute today ... the hepatitis C (hep C) epidemic in the U.S., ... treatments to reduce human suffering. The report examines key ... of hep C, while highlighting the significance of breakthroughs ... treatment. CHI is a nonprofit, public policy research organization, ...
(Date:7/29/2014)... Dennis Thompson HealthDay Reporter ... deadly Ebola virus that continues to rage throughout West Africa ... Ebola only spreads through physical touch, and it can,t ... Stephan Monroe, deputy director of the National Center for Emerging ... Control and Prevention, explained in a Monday afternoon news conference. ...
(Date:7/29/2014)... and aptitudes of Vietnam War veterans who suffered penetrating ... and beginning to answer -- longstanding questions about how ... regions that contribute to optimal social functioning also are ... finding bolsters the view that general intelligence emerges from ... , The findings are reported in the ...
Breaking Medicine News(10 mins):Health News:Clinical Documentation Improvement Heats Up as Half of US Hospitals Make 2015 Preparations for ICD-10, the Rest to Rely on Outsourcers, Black Book Survey Reveals 2Health News:Clinical Documentation Improvement Heats Up as Half of US Hospitals Make 2015 Preparations for ICD-10, the Rest to Rely on Outsourcers, Black Book Survey Reveals 3Health News:Prestigious Crohn's and Colitis Canada grants fund promising Canadian research 2Health News:CHI Releases Report Highlighting Public Impact of Hepatitis C, Opportunities for Action in US 2Health News:CHI Releases Report Highlighting Public Impact of Hepatitis C, Opportunities for Action in US 3Health News:CHI Releases Report Highlighting Public Impact of Hepatitis C, Opportunities for Action in US 4Health News:CDC Downplays Ebola's Threat to the United States 2Health News:CDC Downplays Ebola's Threat to the United States 3Health News:CDC Downplays Ebola's Threat to the United States 4Health News:Team studies the social origins of intelligence in the brain 2Health News:Team studies the social origins of intelligence in the brain 3
... have found a set of "master switches" that keep ... the switches' code may one day enable scientists to ... cancer and other bone marrow disorders. ,The ... level, but farther down the protein production line in ...
... improve their infrastructure to prevent and manage outbreaks of dengue. ... Health Organisation (WHO) meeting to chart a roadmap to improve ... is a prevailing disease for the past two to three ... ,The WHO says the frequency of dengue outbreaks ...
... HIV Vaccine Trials Network (HVTN) this week launched the African ... (Ad5 gag/pol/nef) vaccine. The investigators hope to enroll 3,000 HIV-negative ... to last four years. ,The first Phase IIb ... the Caribbean and Australia in 2005, and was known as ...
... of Current Directions in Psychological Science suggests that the ... genes during post-copulation as well, a phenomenon dubbed "sperm ... Aaron Getz at Florida Atlantic University describe sperm competition ... ,For a monogamous species, sperm competition ...
... the viability of an approach to routinely detect the ... accurately diagnose or rule// out genetic defects - as ... presented at the 27th Annual Meeting of the Society ... ,This future diagnostic technology, currently under ...
... a group of Spanish scientists, amongst which were members ... and the Centre for Applied Medical Research// (CIMA) of ... of treatment for patients with acute lymphoblastic leukemia. ... in the official journal, Blood, of the American Haematology ...
Cached Medicine News:Health News:Master Switches Found for Adult Blood Stem Cells 2Health News:WHO Urges Asian Countries To Improve Infrastructure To Tackle Dengue 2Health News:Largest Ever African HIV Vaccine Trial Opens in South Africa 2Health News:Males Adapt To Battle With Competing Sperm 2Health News:New Approach to Routine Prenatal Genetic Testing 2Health News:A New Treatment Discovered For Acute Lymphoblastic Leukemia 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: